ARID3A Blocking Peptide (C-Term)
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q99856 |
---|
Gene ID | 1820 |
---|---|
Other Names | AT-rich interactive domain-containing protein 3A, ARID domain-containing protein 3A, B-cell regulator of IgH transcription, Bright, Dead ringer-like protein 1, E2F-binding protein 1, ARID3A, DRIL1, DRIL3, DRX, E2FBP1 |
Target/Specificity | The synthetic peptide sequence is selected from aa 449-462 of HUMAN ARID3A |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | ARID3A |
---|---|
Synonyms | DRIL1, DRIL3, DRX, E2FBP1 |
Function | Transcription factor which may be involved in the control of cell cycle progression by the RB1/E2F1 pathway and in B-cell differentiation. |
Cellular Location | Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000269|PubMed:17400556}. Cytoplasm Note=Shuttles between nucleus and cytoplasm |
Tissue Location | Widely expressed, with highest expression in skeletal muscle, thalamus, and colon |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Transcription factor which may be involved in the control of cell cycle progression by the RB1/E2F1 pathway and in B-cell differentiation.
References
Kortschak R.D.,et al.Genomics 51:288-292(1998).
Suzuki M.,et al.Oncogene 17:853-865(1998).
Paulin Y.G.,et al.Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
Grimwood J.,et al.Nature 428:529-535(2004).
Peeper D.S.,et al.Nat. Cell Biol. 4:148-153(2002).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.